Target intelligence / Profile preview

AKTIP pseudogene 3 (AKTIPP3)

Target
AKTIPP3
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

AKTIP pseudogene 3 (AKTIPP3) is a pseudogene, which means it is a segment of DNA that closely resembles the sequence of the functional *AKTIP* gene but has accumulated disabling mutations that prevent it from coding for a functional protein[1][5][3]. Pseudogenes are typically regarded as nonfunctional remnants of evolutionarily duplicated or retrotransposed genes[1][5]. While some pseudogenes across the genome may exert regulatory influence (e.g., through RNA transcripts), the majority—including AKTIP pseudogene 3—are not known to have any current biological or clinical significance[1][3][5][6]. The true, protein-coding AKTIP gene has recognized roles in cell signaling and cancer, but AKTIPP3 is merely a vestigial sequence and does not function as a receptor, enzyme, transporter, or other drug target[2][4].

02

Mechanism of action

Not applicable

03

Biological functions

None established; pseudogenes are generally nonfunctional, but some may have minor regulatory effects at the RNA level in specific contexts[3][1][6]. No direct evidence of function exists for AKTIP pseudogene 3.
04

Disease associations

None established; there are no known implications of AKTIP pseudogene 3 in any disease. The functional protein-coding *AKTIP* gene itself has some roles in cancer biology[2], but the pseudogene form does not participate in these processes.

Beyond the preview

Go deeper on AKTIP pseudogene 3 (AKTIPP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AKTIP pseudogene 3 (AKTIPP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call